Progress and prospect of inhaled biological agents in asthma
10.12092/j.issn.1009-2501.2024.04.007
- Author:
Guanghui LI
1
;
Jing HUANG
1
;
Min ZHU
1
;
Yakun WAN
1
;
Zhihong CHEN
2
;
Rui ZHAO
3
Author Information
1. Shanghai Novamab Biopharmaceuticals Co. Ltd.
2. Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University
3. Shanghai Donghai Geriatric Nursing Hospital
- Publication Type:Journal Article
- Keywords:
administration by inhalation;
asthma;
biologics;
route of administration
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2024;29(4):406-414
- CountryChina
- Language:Chinese
-
Abstract:
More than 300 million people worldwide suffer from asthma, and the incidence is increasing year by year. As one of the most common chronic diseases, asthma is an immune-mediated inflammatory disease with complex triggering mechanisms and strong heterogeneity. With the in-depth study of physiological and pathological mechanisms, therapeutic small molecule and hormone drugs have been introduced to control and treat most patients, but about 5% - 10% of patients still suffer from various subtypes of difficult to control and treat asthma, that is, severe asthma. In the past decade, with the rapid development of bio-pharmaceutical research, protein and antibody have become the key drugs for the treatment of severe asthma with high efficacy, high specificity and high safety. However, biological drugs are usually administered by injection, they cannot be noninvasive and directly delivered into the lung to quickly absorb and take effect. Therefore, there is an urgent need for the introduction of inhaled biologics with quick effectiveness, convenience, economy and safety in clinical. The review summarizes the existing small molecule, hormone and biological therapy drugs, and summarizes the development of inhalable biological agents of asthma, and analyzes the future prospects of the inhalable biological drugs, which is designed to deepen the perception of the direction of the inhalable biological drugs research, and update the information of the field, in order to provide reference for the development of more inhalable biologics.
